Profound Medical (PROF) Cash from Financing Activities (2024 - 2025)
Profound Medical (PROF) recorded quarterly Cash from Financing Activities of $41.4 million in Q4 2025, up 14385.52% quarter-over-quarter from -$290000.0 in Q1 2025, and up 16.91% on a YoY basis from $35.4 million in Q4 2024.
Profound Medical (PROF) Cash from Financing Activities (2024 - 2025) Analysis & Trends
Profound Medical's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at $41.4 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 16.91% year-over-year to $41.4 million; the TTM figure through Dec 2025 stood at $41.1 million (down 24.79% YoY), while the FY2025 annual figure was $41.1 million, down 24.79% from the prior year.
- Cash from Financing Activities was $41.4 million for Q4 2025 at Profound Medical, up from -$290000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $41.4 million in Q4 2025 to a low of -$603000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Profound Medical | 240.29 Mn | 190.00 Mn | 3.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.43 Mn |
| Dec 31, 2025 | 41.43 Mn |
| Mar 31, 2025 | -290,000.00 |
| Mar 31, 2025 | -290,000.00 |
| Dec 31, 2024 | 35.44 Mn |
| Dec 31, 2024 | 35.44 Mn |
| Sep 30, 2024 | -592,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Mar 31, 2024 | 20.46 Mn |
| Mar 31, 2024 | 20.46 Mn |